A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if giving the anti-HIV drug nevirapine (NVP) to
HIV-positive pregnant women and their babies can help reduce the chance that a mother will
give HIV to her baby during delivery. This study will also test the safety of the drug and
see how well it is tolerated by the mother and her baby.
Previous studies suggest that NVP is a promising medication for blocking HIV transmission
from HIV-positive mothers to their babies.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)